phase I clinical study
AstraZeneca, Daiichi Sankyo Unveil First Datopotamab Deruxtecan TNBC Data at SABCS
The companies will conduct a Phase III trial of datopotamab deruxtecan following positive results from a Phase I TNBC cohort presented at the meeting.
Bellicum Pharmaceuticals Nets $35 Million in Private Placement to Advance CAR T-Cell Pipeline
The firm plans to put the funds into developing its GoCAR-T platform therapies, BPX-601 and BPX-603, in certain solid tumors.
NGM Biopharmaceuticals, Merck to Study ILT2/4 Inhibitor Plus Keytruda in Solid Tumors
The companies inked a collaboration to study the drug combination in advanced solid tumors with elevated expression of ILT2 and ILT4.
Notable Labs, CicloMed Partner on AML Trial With Goal to ID Responders
Notable will use its ex vivo functional precision medicine platform to predict which patients respond to CicloMed's fosciclopirox.
Celularity Garners IND Clearance for NK-Cell Therapy, Immunotherapy Combo Trial
With the FDA's permission, the company will now explore the activity of its off-the-shelf cell therapy with Keytruda and Herceptin in advanced gastric cancer patients.